News Releases

<< Back
Waters Corporation Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference to Be Webcast Live

MILFORD, Mass.--(BUSINESS WIRE)--Feb. 4, 2004--Waters Corporation (NYSE:WAT), John Ornell, Chief Financial Officer, will speak to the investment community tomorrow, February 5th, at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference at The Grand Hyatt Hotel in New York, at 8:10 a.m.

Interested investors can access the live webcast of the presentation through Waters website, www.waters.com under "What's New" and the title "Waters Presents at Merrill Lynch Conference". A replay of the webcast will be available until February 11th at 12:00 midnight eastern time.

Waters Corporation holds worldwide leading positions in three complementary analytical technologies - high performance liquid chromatography (HPLC), mass spectrometry (MS), and thermal analysis (TA). These account for $4.4 billion of the overall $20 billion analytical instrumentation market.

CONTACT: Waters Corporation
Gene Cassis, 508-482-2349
V.P. Investor Relations